BioSpace News Archive

Moderna, Inc. announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update.

- Updated adagrasib (MRTX849) clinical data in non-small cell lung cancer (NSCLC) patients will be featured in a plenary session at ENA - Updated adagrasib clinical data in colorectal cancer (CRC) and other KRAS G12C positive solid tumors outside of NSCLC will be presented in a second session at ENA - Mirati to host virtual investor event on October 25th to discuss adagrasib clinical data presented at ENA and provide an update on MRTX1133, the Company’s KRAS G12D selective in

Company name: Er-Kim Ilac Presentative: Cem Zorlular, CEO AnGes, Inc., a Japanese biopharmaceutical company focused on gene-based medicines and Er-Kim, a leading Turkish specialty pharma company; today announce an exclusive licensing and distribution agreement for Er-Kim to commercialize AnGes’ gene therapy product Collategene® for Critical Limb Ischemia patients in Turkey. Under the terms of the agreement,

IntelGenx Technologies Corp. announces the closing of an offering by way of private placement to certain investors in the United States of U.S.$1.2 million principal amount of 8% convertible notes due October 15, 2024.

NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics

Aligos Therapeutics, Inc. announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share.

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc., a provider of wound and skin care products and virtual consult services dedicated to improving patient outcomes, announced that Bob DeSutter has been appointed to the Company’s Board of Directors, effective October 12, 2020.

The Lubrizol Corporation has announced that the Contract Development and Manufacturing Organization (CDMO) Division of Lubrizol Life Science Health (LLS Health) is expanding its product development partnership with the Population Council, an international nongovernmental non-profit organization conducting research around critical health and development issues.

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the third quarter 2020 after the market close on Wednesday, November 4, 2020. The Company’s management will host a conference call to the discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today the expanded availability of the CapsoCam Plus® video capsule system,